Impact of COVID-19 on Incidence, Treatment, and Survival of Patients with Hepatocellular Carcinoma in the Netherlands

Alicia Furumaya*, Otto M. van Delden, Roeland F. de Wilde, Judith de Vos-Geelen, Lydia G. van der Geest, Dutch Hepatocellular & Cholangiocarcinoma Group (DHCG), Covid Cancer Care NL Consortium

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Impact of COVID-19 on Incidence, Treatment, and Survival of Patients with Hepatocellular Carcinoma in the Netherlands'. Together they form a unique fingerprint.

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry